Clearside Biomedical, Inc. Completes $16 Million Series B Financing

Summary Sentence: 
Funds to go to continued development of suprachoidal space (SPS) drug administration.
Story Link: 
In the News Thumbnail: 
sites/default/files/styles/125px_square/public/InTheNews/ClearsideBio-square.jpg
Updated Date: 
09/02/2014 - 09:59